Showing 151-160 of 334 grants

Title Institution Researcher Program Duration Total Award Amount
Localized delivery of costimulatory inhibitors and tolerogenic stromal cells for targeted immunomodulation in beta cell replacement University of Miami Alice Tomei Cures 01-February-2024 to 31-January-2027 $750.000,00
Implementing Best Practice Advisories to Reduce Inequities in Technology Use for people with Type 1 Diabetes T1D Exchange, Inc. Nicole Rioles Improving Lives 01-May-2024 to 30-April-2027 $1.995.534,06
Harnessing insulin signaling in β-cells to counter type 1 diabetes Joslin Diabetes Center Inc. Namrata Shukla Cures 01-March-2024 to 28-February-2027 $228.995,00
Antigen-specific immunotherapies based on ignored ß-cell antigen determinants. The Regents of the University of California, Los Angeles Daniel Kaufman Cures 01-October-2024 to 30-September-2026 $573.101,00
Bringing Beta Cell Regenerative Therapy to the Clinic Icahn School of Medicine at Mount Sinai Andrew Stewart Cures 01-January-2024 to 31-December-2026 $1.000.000,00
Mechanisms of parathyroid protection of transplanted islets The Regents of the University of California, San Francisco Peng Xiao Cures 01-March-2024 to 28-February-2027 $228.995,00
Structural approaches to understand biased insulin signaling and design glucose-binding proteins for smart insulin therapeutics University of Utah Amber Vogel Improving Lives 01-March-2024 to 28-February-2027 $228.995,00
AID pattern search engine for algorithm adaptation informing fully automated closed loop Rector & Visitors of the University of Virginia Tobore Igbe Improving Lives 01-March-2024 to 28-February-2026 $66.500,00
Treating Type 1 Diabetes: Role of Kisspeptin Rutgers Biomedical and Health Sciences Moshmi Bhattacharya Cures 01-April-2024 to 31-March-2026 $140.000,00
Defining the role of islet-derived extracellular vesicle PD-L1 cargo in type-1 diabetes Trustees of Indiana University Chaitra Rao Cures 01-March-2024 to 30-April-2027 $228.537,45